Healthpeak Properties (NYSE:DOC) Stock: Insider Ankit Patadia Sells 6,115 Shares

Healthpeak Properties, Inc. (NYSE:DOC) EVP Ankit Patadia sold 6,115 shares of the stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $20.78, for a total transaction of $127,069.70. Following the completion of the transaction, the executive vice president owned 2,838 shares of the company’s stock, valued at $58,973.64. This represents a 68.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Healthpeak Properties Stock Down 0.9%

Shares of NYSE DOC opened at $20.44 on Wednesday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.87. Healthpeak Properties, Inc. has a 52 week low of $15.70 and a 52 week high of $22.95. The firm has a 50-day moving average price of $19.73 and a 200 day moving average price of $19.22. The stock has a market capitalization of $14.09 billion, a price-to-earnings ratio of 37.85, a price-to-earnings-growth ratio of 2.54 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Monday, November 2nd. The real estate investment trust reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.41). Healthpeak Properties had a return on equity of 4.04% and a net margin of 12.32%. The company had revenue of $820.89 million for the quarter, compared to analyst estimates of $739.18 million. During the same quarter in the previous year, the company posted $0.46 earnings per share. The company’s quarterly revenue was up 16.3% compared to the same quarter last year. Equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 18th will be paid a dividend of $0.1017 per share. The ex-dividend date of this dividend is Friday, December 18th. This represents a $1.22 annualized dividend and a dividend yield of 6.0%. Healthpeak Properties’s payout ratio is 225.93%.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. Private Advisor Group LLC boosted its stake in shares of Healthpeak Properties by 733.2% during the 3rd quarter. Private Advisor Group LLC now owns 95,365 shares of the real estate investment trust’s stock worth $1,904,000 after purchasing an additional 83,920 shares during the last quarter. Boston Partners lifted its stake in shares of Healthpeak Properties by 157.1% during the third quarter. Boston Partners now owns 429,245 shares of the real estate investment trust’s stock valued at $8,572,000 after buying an additional 262,268 shares during the period. Composition Wealth LLC purchased a new position in shares of Healthpeak Properties during the third quarter valued at approximately $223,000. Cibc World Market Inc. lifted its stake in shares of Healthpeak Properties by 2.7% during the third quarter. Cibc World Market Inc. now owns 75,100 shares of the real estate investment trust’s stock valued at $1,500,000 after buying an additional 1,993 shares during the period. Finally, Edgestream Partners L.P. acquired a new stake in Healthpeak Properties during the third quarter worth approximately $288,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. Citigroup raised their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Tuesday, August 11th. Wells Fargo & Company lowered their target price on Healthpeak Properties from $22.00 to $19.00 and set an “equal weight” rating on the stock in a report on Monday, October 19th. Weiss Ratings raised Healthpeak Properties from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday. Wall Street Zen cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Saturday. Finally, UBS Group dropped their price target on Healthpeak Properties from $21.50 to $20.00 and set a “neutral” rating for the company in a research report on Tuesday, October 13th. Four investment analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company. Based on data from MarketBeat.com, Healthpeak Properties has an average rating of “Hold” and an average price target of $21.47.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc. is a real estate investment trust that owns and operates properties serving the healthcare and life sciences industries. Its portfolio includes outpatient medical buildings, life science facilities and senior housing communities. The company’s properties are located across the United States, with investments in major healthcare and life science markets. In 2024, Healthpeak completed its merger with Physicians Realty Trust, expanding its portfolio of outpatient medical properties.